| Date Filed | Type | Description |
| 02/16/2021 |
SC 13G/A
| Palo Alto Investors LP reports a 0% stake in AMAG Pharmaceuticals, Inc. |
| 02/16/2021 |
SC 13G/A
| Camber Capital Management LP reports a 0% stake in AMAG Pharmaceuticals, Inc. |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/14/2020 |
GN
| AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration's Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection) |
| 11/27/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 11/16/2020 |
SC 13D/A
| Caligan Partners LP reports a 0% stake in AMAG Pharmaceuticals, Inc. |
| 11/16/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/16/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/13/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/13/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/06/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 11/06/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/30/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of AMAG Pharmaceuticals, Inc., Eaton Vance Corp., MobileIron, Inc., and Seacoast Commerce Banc Holdings |
| 10/26/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/26/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/15/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of AMAG Pharmaceuticals, Inc. Buyout |
| 10/15/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), MobileIron, Inc. (NASDAQ GS: MOBL), Seacoast Commerce Banc Holdings (OTC: SCBH), and Perceptron, Inc. (NASDAQ GS: PRCP) |
| 10/15/2020 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 10/15/2020 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 10/14/2020 |
GN
| AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients |
| 10/13/2020 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 10/13/2020 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 10/13/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 10/07/2020 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 0% stake in AMAG Pharmaceuticals, Inc. |
| 10/07/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of AMAG Pharmaceuticals, Inc., MobileIron, Inc., Monaker Group, Inc., and Seacoast Commerce Banc Holdings |
| 10/05/2020 |
8-K
| Quarterly results |
| 10/05/2020 |
GN
| AMAG Pharmaceuticals Provides Update on FDA's Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection) |
| 10/02/2020 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 10/01/2020 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 10/01/2020 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 10/01/2020 |
8-K
| Quarterly results |
| 10/01/2020 |
GN
| Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals |
| 09/15/2020 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 09/15/2020 |
10-K/A
| Annual Report for the period ended December 31, 2019 [amend] |
|